NO20075463L - Tetrahydrotiopyranopyrazolcannabinoidmodulatorer kryssreferanse til beslektede soknader - Google Patents
Tetrahydrotiopyranopyrazolcannabinoidmodulatorer kryssreferanse til beslektede soknaderInfo
- Publication number
- NO20075463L NO20075463L NO20075463A NO20075463A NO20075463L NO 20075463 L NO20075463 L NO 20075463L NO 20075463 A NO20075463 A NO 20075463A NO 20075463 A NO20075463 A NO 20075463A NO 20075463 L NO20075463 L NO 20075463L
- Authority
- NO
- Norway
- Prior art keywords
- tetrahydrotiopyranopyrazole
- modulators cross
- cannabinoid modulators
- related societies
- societies
- Prior art date
Links
- 229930003827 cannabinoid Natural products 0.000 title 1
- 239000003557 cannabinoid Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
CB modulatorforbindelse av formel (I) eller en farmasøytisk akseptabel form derav og en fremgangsmåte for anvendelse i behandling, bedring eller forebyggelse av et CB reseptormediert syndrom, forstyrrelse eller sykdom.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66689805P | 2005-03-31 | 2005-03-31 | |
PCT/US2006/009424 WO2006107561A1 (en) | 2005-03-31 | 2006-03-16 | Tetrahydrothiopyrano pyrazole cannabinoid modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20075463L true NO20075463L (no) | 2007-12-21 |
Family
ID=36587178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20075463A NO20075463L (no) | 2005-03-31 | 2007-10-29 | Tetrahydrotiopyranopyrazolcannabinoidmodulatorer kryssreferanse til beslektede soknader |
Country Status (18)
Country | Link |
---|---|
US (2) | US20060223798A1 (no) |
EP (1) | EP1863479B1 (no) |
JP (1) | JP5127697B2 (no) |
KR (1) | KR20080004559A (no) |
CN (1) | CN101189007A (no) |
AT (1) | ATE416768T1 (no) |
AU (1) | AU2006232945B2 (no) |
BR (1) | BRPI0609790A2 (no) |
CA (1) | CA2603104A1 (no) |
CO (1) | CO6321135A2 (no) |
CR (1) | CR9479A (no) |
DE (1) | DE602006004197D1 (no) |
EA (1) | EA200702130A1 (no) |
IL (1) | IL186430A0 (no) |
MX (1) | MX2007012233A (no) |
NO (1) | NO20075463L (no) |
WO (1) | WO2006107561A1 (no) |
ZA (1) | ZA200709342B (no) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101863903B (zh) * | 2010-06-08 | 2014-03-12 | 沈阳药科大学 | 1,4-二氢噻吩并[3’,2’:5,6]噻喃并[4,3-c]吡唑-3-羧酸衍生物及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2800375B1 (fr) * | 1999-11-03 | 2004-07-23 | Sanofi Synthelabo | Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant |
CA2399791A1 (en) * | 2000-02-11 | 2001-08-16 | Bristol-Myers Squibb Company | Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
EP1448557A4 (en) * | 2001-10-26 | 2005-02-02 | Univ Connecticut | HETEROINDANE: A NEW CLASS OF HIGH-ACTIVITY CANNABIMIMETIC LIGANDS |
US7145012B2 (en) * | 2003-04-23 | 2006-12-05 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
US20040214856A1 (en) * | 2003-04-23 | 2004-10-28 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
-
2006
- 2006-03-16 US US11/376,844 patent/US20060223798A1/en not_active Abandoned
- 2006-03-16 BR BRPI0609790-1A patent/BRPI0609790A2/pt not_active IP Right Cessation
- 2006-03-16 JP JP2008504108A patent/JP5127697B2/ja not_active Expired - Fee Related
- 2006-03-16 MX MX2007012233A patent/MX2007012233A/es active IP Right Grant
- 2006-03-16 AU AU2006232945A patent/AU2006232945B2/en not_active Ceased
- 2006-03-16 DE DE602006004197T patent/DE602006004197D1/de active Active
- 2006-03-16 EA EA200702130A patent/EA200702130A1/ru unknown
- 2006-03-16 EP EP06738484A patent/EP1863479B1/en active Active
- 2006-03-16 KR KR1020077025259A patent/KR20080004559A/ko not_active Application Discontinuation
- 2006-03-16 CN CNA2006800192594A patent/CN101189007A/zh active Pending
- 2006-03-16 AT AT06738484T patent/ATE416768T1/de not_active IP Right Cessation
- 2006-03-16 CA CA002603104A patent/CA2603104A1/en not_active Abandoned
- 2006-03-16 WO PCT/US2006/009424 patent/WO2006107561A1/en active Application Filing
-
2007
- 2007-10-07 IL IL186430A patent/IL186430A0/en unknown
- 2007-10-17 CO CO07109275A patent/CO6321135A2/es not_active Application Discontinuation
- 2007-10-29 CR CR9479A patent/CR9479A/es not_active Application Discontinuation
- 2007-10-29 NO NO20075463A patent/NO20075463L/no not_active Application Discontinuation
- 2007-10-30 ZA ZA200709342A patent/ZA200709342B/xx unknown
- 2007-12-07 US US11/952,375 patent/US7524964B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
MX2007012233A (es) | 2008-03-18 |
CN101189007A (zh) | 2008-05-28 |
IL186430A0 (en) | 2008-01-20 |
CO6321135A2 (es) | 2011-09-20 |
ATE416768T1 (de) | 2008-12-15 |
KR20080004559A (ko) | 2008-01-09 |
DE602006004197D1 (de) | 2009-01-22 |
WO2006107561A1 (en) | 2006-10-12 |
EP1863479B1 (en) | 2008-12-10 |
AU2006232945A1 (en) | 2006-10-12 |
CR9479A (es) | 2008-09-09 |
JP5127697B2 (ja) | 2013-01-23 |
AU2006232945B2 (en) | 2012-02-23 |
US20080085899A1 (en) | 2008-04-10 |
US20060223798A1 (en) | 2006-10-05 |
BRPI0609790A2 (pt) | 2010-04-27 |
JP2008535829A (ja) | 2008-09-04 |
CA2603104A1 (en) | 2006-10-12 |
US7524964B2 (en) | 2009-04-28 |
EP1863479A1 (en) | 2007-12-12 |
ZA200709342B (en) | 2009-09-30 |
EA200702130A1 (ru) | 2008-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20064810L (no) | Tetrahydro-indazolcannabinoid-modulatorer | |
NO20072352L (no) | Forbindelser og sammensetninger som inhibitorer av cannabinoidreceptor 1-aktivitet | |
TW200610528A (en) | Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto | |
NO20070910L (no) | Pyrrolderivater som farmasoytiske middel | |
NO20081975L (no) | Diarylamin-inneholdende forbindelser og sammensetninger, og deres anvendelse som modulatorer av C-kit-reseptorer | |
NO20081810L (no) | Modulatorer av metabolisme og behandling av lidelser relatert dertil | |
NO20084374L (no) | Imidazoltiazolforbindelser for behandling av sykdom | |
DK1913001T3 (da) | (r)-n-methylnaltrexon, fremgangsmåder til syntese og farmaceutisk anvendelse heraf | |
EP2217596B8 (en) | Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 | |
TW200745124A (en) | Azepinoindole derivatives as pharmaceutical agents | |
NO20074943L (no) | Roflumilast for behandlingen av diabetes mellitus | |
NO20081788L (no) | Cyklopropylaminer som modulatorer av histamin-H3-reseptoren | |
ATE458480T1 (de) | Hexahydro-cyclooctyl-pyrazol-cannabinoid- modulatoren | |
ATE489371T1 (de) | Benzamidglucokinaseaktivatoren | |
NO20056073L (no) | Sammensetninger og fremgangsmater til behandling av alvorlig akutt respitatorisk syndrom (SARS) | |
NO341679B1 (no) | Substituerte pyridylamidforbindelser, fremstilling av slike og farmasøytiske sammensetninger inneholdende slike, samt anvendelse som modulatorer av histamin H3-reseptoren | |
WO2010021717A3 (en) | Hcv protease inhibitors | |
NO20082505L (no) | Substtuert 5-heteroaryl-1-fenyl-pyrazol-cannabinoid-modulatorer | |
WO2009071689A3 (de) | 5-halogen-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen | |
NO20092073L (no) | Modulatorer av C3A-reseptor, og fremgangsmater for anvendelse derav | |
DE502006001195D1 (de) | Transdermales therapeutisches system zur verabreichung von analgetika | |
WO2009023653A3 (en) | Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators | |
NO20092763L (no) | Isosorbid mononitrat derivater for behandling av tarmlidelser | |
NO20092134L (no) | Kombinasjonsprodukt for bruk i behandling av inflammatoriske lidelser | |
WO2008115705A3 (en) | Hexahydro-cycloheptapyrazole cannabinoid modulators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |